Aclaris Therapeutics (ACRS) Interest Coverage Ratio Growth (1y) (2015 - 2026)
Aclaris Therapeutics (ACRS) Interest Coverage Ratio Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,801.52 Bn | 66,801.23 Bn | - | -60.44% |
| 2 | Nanobiotix | 1,916.61 Bn | 1,916.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -347.04% |
| 4 | BeOne Medicines | 471.65 Bn | 466.85 Bn | 1.35 Bn | 787.12% |
| 5 | Vertex Pharmaceuticals | 121.94 Bn | 114.69 Bn | 2.59 Bn | 53.59% |
| 6 | Regeneron Pharmaceuticals | 69.85 Bn | 61.09 Bn | 3.31 Bn | -32.04% |
| 7 | Belite Bio | 63.06 Bn | 63.06 Bn | - | - |
| 8 | Argenx Se | 55.74 Bn | 50.56 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.48 Bn | 37.48 Bn | - | 73.00% |
| 10 | Aclaris Therapeutics | 689.78 Mn | 584.36 Mn | 1.60 Mn | 93.80% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 93.80% |
| Dec 31, 2025 | 92.13% |
| Sep 30, 2025 | 93.85% |
| Jun 30, 2025 | -35.57% |
| Mar 31, 2025 | 37.30% |
| Dec 31, 2024 | 88.38% |
| Sep 30, 2024 | -1,406.54% |
| Jun 30, 2024 | -442.02% |
| Mar 31, 2024 | -516.26% |
| Dec 31, 2023 | -183,496.49% |
| Sep 30, 2023 | -532.06% |
| Jun 30, 2023 | -155.10% |
| Mar 31, 2023 | -512.37% |
| Dec 31, 2022 | -11.30% |
| Sep 30, 2022 | -21.41% |
| Jun 30, 2022 | -89.07% |
| Mar 31, 2022 | -14.57% |
| Dec 31, 2021 | -40.38% |
| Sep 30, 2021 | 87.79% |
| Jun 30, 2021 | 97.15% |